0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Viral Vector Manufacturing - Global Market Insights and Sales Trends 2024
Published Date: December 2023
|
Report Code: QYRE-Auto-13J2823
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Viral Vector Manufacturing Market Insights and Forecast to 2028
BUY CHAPTERS

Viral Vector Manufacturing - Global Market Insights and Sales Trends 2024

Code: QYRE-Auto-13J2823
Report
December 2023
Pages:101
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Viral Vector Manufacturing - Market Size

The global Viral Vector Manufacturing market size is expected to reach US$ 678.8 million by 2029, growing at a CAGR of 4.9% from 2023 to 2029.

Viral Vector Manufacturing -  Market

Viral Vector Manufacturing - Market

Viral vectors represent one of the primary tools, which can be used to deliver the genetic material into cells.
The market is mainly driven by the significant applications of Viral Vector Manufacturing in various end use industries. The expanding demands from the Gene Therapy and Vaccinology, are propelling Viral Vector Manufacturing market. Adenoviral Vectors, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Adeno-associated Viral Vectors segment is estimated at % CAGR for the next seven-year period.
Viral vectors can be utilized in gene therapy for the treatment of different diseases, such as heart defects, metabolic diseases, cancer, and neurodegenerative disorders. Viral vectors based on adenoviruses, adeno-associated viruses, lentiviruses, retroviruses, herpes simplex viruses, baculovirus, etc. are being routinely used in life sciences research and are finding applications in vaccinology and novel drug delivery approaches.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Viral Vector Manufacturing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Viral Vector Manufacturing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Viral Vector Manufacturing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Viral Vector Manufacturing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Viral Vector Manufacturing covered in this report include BioReliance, Cobra Biologics, Oxford BioMedica, UniQure, FinVector, MolMed, MassBiologics, FUJIFILM Diosynth Biotechnologies and Lonza, etc.
The global Viral Vector Manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
FUJIFILM Diosynth Biotechnologies
Lonza
Biovian
Thermo Fisher Scientific (Brammer Bio)

Scope of Viral Vector Manufacturing - Market Report

Report Metric Details
Report Name Viral Vector Manufacturing - Market
Forecasted market size in 2029 US$ 678.8 million
CAGR 4.9%
Forecasted years 2023 - 2029
Global Viral Vector Manufacturing market, by region:
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Viral Vector Manufacturing market, Segment by Type:
  • Adenoviral Vectors
  • Adeno-associated Viral Vectors
  • Retroviral Vectors
  • Lentiviral Vectors
  • Other
Global Viral Vector Manufacturing market, by Application
  • Gene Therapy
  • Vaccinology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter Four: Detailed analysis of Viral Vector Manufacturing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
  • Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
  • Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter Twelve: Research Finding/Conclusion

FAQ for this report

What is the Viral Vector Manufacturing - Market size in 2029?

Ans: The Viral Vector Manufacturing - Market size in 2029 will be US$ 678.8 million.

What are the Application segmentation covered in the Viral Vector Manufacturing - Market report?

Ans: The Applications covered in the Viral Vector Manufacturing - Market report are Gene Therapy, Vaccinology

What are the Type segmentation covered in the Viral Vector Manufacturing - Market report?

Ans: The Types covered in the Viral Vector Manufacturing - Market report are Adenoviral Vectors, Adeno-associated Viral Vectors, Retroviral Vectors, Lentiviral Vectors, Other

1 Market Overview of Viral Vector Manufacturing
1.1 Viral Vector Manufacturing Market Overview
1.1.1 Viral Vector Manufacturing Product Scope
1.1.2 Viral Vector Manufacturing Market Status and Outlook
1.2 Global Viral Vector Manufacturing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Viral Vector Manufacturing Market Size by Region (2018-2029)
1.4 Global Viral Vector Manufacturing Historic Market Size by Region (2018-2023)
1.5 Global Viral Vector Manufacturing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Viral Vector Manufacturing Market Size (2018-2029)
1.6.1 North America Viral Vector Manufacturing Market Size (2018-2029)
1.6.2 Europe Viral Vector Manufacturing Market Size (2018-2029)
1.6.3 Asia-Pacific Viral Vector Manufacturing Market Size (2018-2029)
1.6.4 Latin America Viral Vector Manufacturing Market Size (2018-2029)
1.6.5 Middle East & Africa Viral Vector Manufacturing Market Size (2018-2029)
2 Viral Vector Manufacturing Market by Type
2.1 Introduction
2.1.1 Adenoviral Vectors
2.1.2 Adeno-associated Viral Vectors
2.1.3 Retroviral Vectors
2.1.4 Lentiviral Vectors
2.1.5 Other
2.2 Global Viral Vector Manufacturing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Viral Vector Manufacturing Historic Market Size by Type (2018-2023)
2.2.2 Global Viral Vector Manufacturing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Viral Vector Manufacturing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Viral Vector Manufacturing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Viral Vector Manufacturing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Viral Vector Manufacturing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Viral Vector Manufacturing Revenue Breakdown by Type (2018-2029)
3 Viral Vector Manufacturing Market Overview by Application
3.1 Introduction
3.1.1 Gene Therapy
3.1.2 Vaccinology
3.2 Global Viral Vector Manufacturing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Viral Vector Manufacturing Historic Market Size by Application (2018-2023)
3.2.2 Global Viral Vector Manufacturing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Viral Vector Manufacturing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Viral Vector Manufacturing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Viral Vector Manufacturing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Viral Vector Manufacturing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Viral Vector Manufacturing Revenue Breakdown by Application (2018-2029)
4 Viral Vector Manufacturing Competition Analysis by Players
4.1 Global Viral Vector Manufacturing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Viral Vector Manufacturing as of 2022)
4.3 Date of Key Players Enter into Viral Vector Manufacturing Market
4.4 Global Top Players Viral Vector Manufacturing Headquarters and Area Served
4.5 Key Players Viral Vector Manufacturing Product Solution and Service
4.6 Competitive Status
4.6.1 Viral Vector Manufacturing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 BioReliance
5.1.1 BioReliance Profile
5.1.2 BioReliance Main Business
5.1.3 BioReliance Viral Vector Manufacturing Products, Services and Solutions
5.1.4 BioReliance Viral Vector Manufacturing Revenue (US$ Million) & (2018-2023)
5.1.5 BioReliance Recent Developments
5.2 Cobra Biologics
5.2.1 Cobra Biologics Profile
5.2.2 Cobra Biologics Main Business
5.2.3 Cobra Biologics Viral Vector Manufacturing Products, Services and Solutions
5.2.4 Cobra Biologics Viral Vector Manufacturing Revenue (US$ Million) & (2018-2023)
5.2.5 Cobra Biologics Recent Developments
5.3 Oxford BioMedica
5.3.1 Oxford BioMedica Profile
5.3.2 Oxford BioMedica Main Business
5.3.3 Oxford BioMedica Viral Vector Manufacturing Products, Services and Solutions
5.3.4 Oxford BioMedica Viral Vector Manufacturing Revenue (US$ Million) & (2018-2023)
5.3.5 UniQure Recent Developments
5.4 UniQure
5.4.1 UniQure Profile
5.4.2 UniQure Main Business
5.4.3 UniQure Viral Vector Manufacturing Products, Services and Solutions
5.4.4 UniQure Viral Vector Manufacturing Revenue (US$ Million) & (2018-2023)
5.4.5 UniQure Recent Developments
5.5 FinVector
5.5.1 FinVector Profile
5.5.2 FinVector Main Business
5.5.3 FinVector Viral Vector Manufacturing Products, Services and Solutions
5.5.4 FinVector Viral Vector Manufacturing Revenue (US$ Million) & (2018-2023)
5.5.5 FinVector Recent Developments
5.6 MolMed
5.6.1 MolMed Profile
5.6.2 MolMed Main Business
5.6.3 MolMed Viral Vector Manufacturing Products, Services and Solutions
5.6.4 MolMed Viral Vector Manufacturing Revenue (US$ Million) & (2018-2023)
5.6.5 MolMed Recent Developments
5.7 MassBiologics
5.7.1 MassBiologics Profile
5.7.2 MassBiologics Main Business
5.7.3 MassBiologics Viral Vector Manufacturing Products, Services and Solutions
5.7.4 MassBiologics Viral Vector Manufacturing Revenue (US$ Million) & (2018-2023)
5.7.5 MassBiologics Recent Developments
5.8 FUJIFILM Diosynth Biotechnologies
5.8.1 FUJIFILM Diosynth Biotechnologies Profile
5.8.2 FUJIFILM Diosynth Biotechnologies Main Business
5.8.3 FUJIFILM Diosynth Biotechnologies Viral Vector Manufacturing Products, Services and Solutions
5.8.4 FUJIFILM Diosynth Biotechnologies Viral Vector Manufacturing Revenue (US$ Million) & (2018-2023)
5.8.5 FUJIFILM Diosynth Biotechnologies Recent Developments
5.9 Lonza
5.9.1 Lonza Profile
5.9.2 Lonza Main Business
5.9.3 Lonza Viral Vector Manufacturing Products, Services and Solutions
5.9.4 Lonza Viral Vector Manufacturing Revenue (US$ Million) & (2018-2023)
5.9.5 Lonza Recent Developments
5.10 Biovian
5.10.1 Biovian Profile
5.10.2 Biovian Main Business
5.10.3 Biovian Viral Vector Manufacturing Products, Services and Solutions
5.10.4 Biovian Viral Vector Manufacturing Revenue (US$ Million) & (2018-2023)
5.10.5 Biovian Recent Developments
5.11 Thermo Fisher Scientific (Brammer Bio)
5.11.1 Thermo Fisher Scientific (Brammer Bio) Profile
5.11.2 Thermo Fisher Scientific (Brammer Bio) Main Business
5.11.3 Thermo Fisher Scientific (Brammer Bio) Viral Vector Manufacturing Products, Services and Solutions
5.11.4 Thermo Fisher Scientific (Brammer Bio) Viral Vector Manufacturing Revenue (US$ Million) & (2018-2023)
5.11.5 Thermo Fisher Scientific (Brammer Bio) Recent Developments
6 North America
6.1 North America Viral Vector Manufacturing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Viral Vector Manufacturing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Viral Vector Manufacturing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Viral Vector Manufacturing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Viral Vector Manufacturing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Viral Vector Manufacturing Market Dynamics
11.1 Viral Vector Manufacturing Industry Trends
11.2 Viral Vector Manufacturing Market Drivers
11.3 Viral Vector Manufacturing Market Challenges
11.4 Viral Vector Manufacturing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables
    Table 1. Global Market Viral Vector Manufacturing Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
    Table 2. Global Viral Vector Manufacturing Market Size by Region (2018-2023) & (US$ Million)
    Table 3. Global Viral Vector Manufacturing Market Size Share by Region (2018-2023)
    Table 4. Global Viral Vector Manufacturing Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 5. Global Viral Vector Manufacturing Forecasted Market Size Share by Region (2024-2029)
    Table 6. Global Viral Vector Manufacturing Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
    Table 7. Global Viral Vector Manufacturing Market Size by Type (2018-2023) & (US$ Million)
    Table 8. Global Viral Vector Manufacturing Revenue Market Share by Type (2018-2023)
    Table 9. Global Viral Vector Manufacturing Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 10. Global Viral Vector Manufacturing Revenue Market Share by Type (2024-2029)
    Table 11. North America Viral Vector Manufacturing Revenue by Type (2018-2023) & (US$ Million)
    Table 12. North America Viral Vector Manufacturing Revenue by Type (2024-2029) & (US$ Million)
    Table 13. Europe Viral Vector Manufacturing Revenue by Type (2018-2023) & (US$ Million)
    Table 14. Europe Viral Vector Manufacturing Revenue by Type (2024-2029) & (US$ Million)
    Table 15. Asia-Pacific Viral Vector Manufacturing Revenue by Type (2018-2023) & (US$ Million)
    Table 16. Asia-Pacific Viral Vector Manufacturing Revenue by Type (2024-2029) & (US$ Million)
    Table 17. Latin America Viral Vector Manufacturing Revenue by Type (2018-2023) & (US$ Million)
    Table 18. Latin America Viral Vector Manufacturing Revenue by Type (2024-2029) & (US$ Million)
    Table 19. Middle East and Africa Viral Vector Manufacturing Revenue by Type (2018-2023) & (US$ Million)
    Table 20. Middle East and Africa Viral Vector Manufacturing Revenue by Type (2024-2029) & (US$ Million)
    Table 21. Global Viral Vector Manufacturing Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
    Table 22. Global Viral Vector Manufacturing Market Size by Application (2018-2023) & (US$ Million)
    Table 23. Global Viral Vector Manufacturing Revenue Market Share by Application (2018-2023)
    Table 24. Global Viral Vector Manufacturing Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 25. Global Viral Vector Manufacturing Revenue Market Share by Application (2024-2029)
    Table 26. North America Viral Vector Manufacturing Revenue by Application (2018-2023) & (US$ Million)
    Table 27. North America Viral Vector Manufacturing Revenue by Application (2024-2029) & (US$ Million)
    Table 28. Europe Viral Vector Manufacturing Revenue by Application (2018-2023) & (US$ Million)
    Table 29. Europe Viral Vector Manufacturing Revenue by Application (2024-2029) & (US$ Million)
    Table 30. Asia-Pacific Viral Vector Manufacturing Revenue by Application (2018-2023) & (US$ Million)
    Table 31. Asia-Pacific Viral Vector Manufacturing Revenue by Application (2024-2029) & (US$ Million)
    Table 32. Latin America Viral Vector Manufacturing Revenue by Application (2018-2023) & (US$ Million)
    Table 33. Latin America Viral Vector Manufacturing Revenue by Application (2024-2029) & (US$ Million)
    Table 34. Middle East and Africa Viral Vector Manufacturing Revenue by Application (2018-2023) & (US$ Million)
    Table 35. Middle East and Africa Viral Vector Manufacturing Revenue by Application (2024-2029) & (US$ Million)
    Table 36. Global Viral Vector Manufacturing Revenue (US$ Million) by Players (2018-2023)
    Table 37. Global Viral Vector Manufacturing Revenue Market Share by Players (2018-2023)
    Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Viral Vector Manufacturing as of 2022)
    Table 39. Date of Key Players Enter into Viral Vector Manufacturing Market
    Table 40. Global Viral Vector Manufacturing Key Players Headquarters and Area Served
    Table 41. Viral Vector Manufacturing Product Solution and Service
    Table 42. Global Viral Vector Manufacturing Players Market Concentration Ratio (CR5 and HHI)
    Table 43. Mergers & Acquisitions, Expansion Plans
    Table 44. BioReliance Basic Information List
    Table 45. BioReliance Description and Business Overview
    Table 46. BioReliance Viral Vector Manufacturing Products, Services and Solutions
    Table 47. Revenue (US$ Million) in Viral Vector Manufacturing Business of BioReliance (2018-2023)
    Table 48. BioReliance Recent Developments
    Table 49. Cobra Biologics Basic Information List
    Table 50. Cobra Biologics Description and Business Overview
    Table 51. Cobra Biologics Viral Vector Manufacturing Products, Services and Solutions
    Table 52. Revenue (US$ Million) in Viral Vector Manufacturing Business of Cobra Biologics (2018-2023)
    Table 53. Cobra Biologics Recent Developments
    Table 54. Oxford BioMedica Basic Information List
    Table 55. Oxford BioMedica Description and Business Overview
    Table 56. Oxford BioMedica Viral Vector Manufacturing Products, Services and Solutions
    Table 57. Revenue (US$ Million) in Viral Vector Manufacturing Business of Oxford BioMedica (2018-2023)
    Table 58. Oxford BioMedica Recent Developments
    Table 59. UniQure Basic Information List
    Table 60. UniQure Description and Business Overview
    Table 61. UniQure Viral Vector Manufacturing Products, Services and Solutions
    Table 62. Revenue (US$ Million) in Viral Vector Manufacturing Business of UniQure (2018-2023)
    Table 63. UniQure Recent Developments
    Table 64. FinVector Basic Information List
    Table 65. FinVector Description and Business Overview
    Table 66. FinVector Viral Vector Manufacturing Products, Services and Solutions
    Table 67. Revenue (US$ Million) in Viral Vector Manufacturing Business of FinVector (2018-2023)
    Table 68. FinVector Recent Developments
    Table 69. MolMed Basic Information List
    Table 70. MolMed Description and Business Overview
    Table 71. MolMed Viral Vector Manufacturing Products, Services and Solutions
    Table 72. Revenue (US$ Million) in Viral Vector Manufacturing Business of MolMed (2018-2023)
    Table 73. MolMed Recent Developments
    Table 74. MassBiologics Basic Information List
    Table 75. MassBiologics Description and Business Overview
    Table 76. MassBiologics Viral Vector Manufacturing Products, Services and Solutions
    Table 77. Revenue (US$ Million) in Viral Vector Manufacturing Business of MassBiologics (2018-2023)
    Table 78. MassBiologics Recent Developments
    Table 79. FUJIFILM Diosynth Biotechnologies Basic Information List
    Table 80. FUJIFILM Diosynth Biotechnologies Description and Business Overview
    Table 81. FUJIFILM Diosynth Biotechnologies Viral Vector Manufacturing Products, Services and Solutions
    Table 82. Revenue (US$ Million) in Viral Vector Manufacturing Business of FUJIFILM Diosynth Biotechnologies (2018-2023)
    Table 83. FUJIFILM Diosynth Biotechnologies Recent Developments
    Table 84. Lonza Basic Information List
    Table 85. Lonza Description and Business Overview
    Table 86. Lonza Viral Vector Manufacturing Products, Services and Solutions
    Table 87. Revenue (US$ Million) in Viral Vector Manufacturing Business of Lonza (2018-2023)
    Table 88. Lonza Recent Developments
    Table 89. Biovian Basic Information List
    Table 90. Biovian Description and Business Overview
    Table 91. Biovian Viral Vector Manufacturing Products, Services and Solutions
    Table 92. Revenue (US$ Million) in Viral Vector Manufacturing Business of Biovian (2018-2023)
    Table 93. Biovian Recent Developments
    Table 94. Thermo Fisher Scientific (Brammer Bio) Basic Information List
    Table 95. Thermo Fisher Scientific (Brammer Bio) Description and Business Overview
    Table 96. Thermo Fisher Scientific (Brammer Bio) Viral Vector Manufacturing Products, Services and Solutions
    Table 97. Revenue (US$ Million) in Viral Vector Manufacturing Business of Thermo Fisher Scientific (Brammer Bio) (2018-2023)
    Table 98. Thermo Fisher Scientific (Brammer Bio) Recent Developments
    Table 99. North America Viral Vector Manufacturing Market Size by Country (2018-2023) & (US$ Million)
    Table 100. North America Viral Vector Manufacturing Market Size by Country (2024-2029) & (US$ Million)
    Table 101. Europe Viral Vector Manufacturing Market Size by Country (2018-2023) & (US$ Million)
    Table 102. Europe Viral Vector Manufacturing Market Size by Country (2024-2029) & (US$ Million)
    Table 103. Asia-Pacific Viral Vector Manufacturing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 104. Asia-Pacific Viral Vector Manufacturing Market Size by Region (2018-2023) & (US$ Million)
    Table 105. Asia-Pacific Viral Vector Manufacturing Market Size by Region (2024-2029) & (US$ Million)
    Table 106. Asia-Pacific Viral Vector Manufacturing Market Share by Region (2018-2023)
    Table 107. Asia-Pacific Viral Vector Manufacturing Market Share by Region (2024-2029)
    Table 108. Latin America Viral Vector Manufacturing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 109. Latin America Viral Vector Manufacturing Market Size by Country (2018-2023) & (US$ Million)
    Table 110. Latin America Viral Vector Manufacturing Market Size by Country (2024-2029) & (US$ Million)
    Table 111. Middle East & Africa Viral Vector Manufacturing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 112. Middle East & Africa Viral Vector Manufacturing Market Size by Country (2018-2023) & (US$ Million)
    Table 113. Middle East & Africa Viral Vector Manufacturing Market Size by Country (2024-2029) & (US$ Million)
    Table 114. Viral Vector Manufacturing Market Trends
    Table 115. Viral Vector Manufacturing Market Drivers
    Table 116. Viral Vector Manufacturing Market Challenges
    Table 117. Viral Vector Manufacturing Market Restraints
    Table 118. Research Programs/Design for This Report
    Table 119. Key Data Information from Secondary Sources
    Table 120. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Viral Vector Manufacturing Market Size Year-over-Year 2018-2029 & (US$ Million)
    Figure 2. Global Viral Vector Manufacturing Market Size (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Viral Vector Manufacturing Market Share by Regions: 2022 VS 2029
    Figure 4. Global Viral Vector Manufacturing Forecasted Market Size Share by Region (2024-2029)
    Figure 5. North America Viral Vector Manufacturing Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 6. Europe Viral Vector Manufacturing Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 7. Asia-Pacific Viral Vector Manufacturing Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 8. Latin America Viral Vector Manufacturing Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 9. Middle East & Africa Viral Vector Manufacturing Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 10. Product Picture of Adenoviral Vectors
    Figure 11. Global Adenoviral Vectors Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 12. Product Picture of Adeno-associated Viral Vectors
    Figure 13. Global Adeno-associated Viral Vectors Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 14. Product Picture of Retroviral Vectors
    Figure 15. Global Retroviral Vectors Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 16. Product Picture of Lentiviral Vectors
    Figure 17. Global Lentiviral Vectors Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 18. Product Picture of Other
    Figure 19. Global Other Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 20. Global Viral Vector Manufacturing Market Size Share by Type: 2022 & 2029
    Figure 21. North America Viral Vector Manufacturing Revenue Market Share by Type (2018-2029)
    Figure 22. Europe Viral Vector Manufacturing Revenue Market Share by Type (2018-2029)
    Figure 23. Asia-Pacific Viral Vector Manufacturing Revenue Market Share by Type (2018-2029)
    Figure 24. Latin America Viral Vector Manufacturing Revenue Market Share by Type (2018-2029)
    Figure 25. Middle East and Africa Viral Vector Manufacturing Revenue Market Share by Type (2018-2029)
    Figure 26. Gene Therapy Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 27. Vaccinology Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 28. Global Viral Vector Manufacturing Market Size Share by Application: 2022 & 2029
    Figure 29. North America Viral Vector Manufacturing Revenue Market Share by Application (2018-2029)
    Figure 30. Europe Viral Vector Manufacturing Revenue Market Share by Application (2018-2029)
    Figure 31. Asia-Pacific Viral Vector Manufacturing Revenue Market Share by Application (2018-2029)
    Figure 32. Latin America Viral Vector Manufacturing Revenue Market Share by Application (2018-2029)
    Figure 33. Middle East and Africa Viral Vector Manufacturing Revenue Market Share by Application (2018-2029)
    Figure 34. Viral Vector Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 35. Global Top 5 and Top 10 Players Viral Vector Manufacturing Market Share in 2022
    Figure 36. North America Viral Vector Manufacturing Market Share by Country (2018-2029)
    Figure 37. U.S. Viral Vector Manufacturing Market Size (2018-2029) & (US$ Million)
    Figure 38. Canada Viral Vector Manufacturing Market Size (2018-2029) & (US$ Million)
    Figure 39. Germany Viral Vector Manufacturing Market Size (2018-2029) & (US$ Million)
    Figure 40. France Viral Vector Manufacturing Market Size (2018-2029) & (US$ Million)
    Figure 41. U.K. Viral Vector Manufacturing Market Size (2018-2029) & (US$ Million)
    Figure 42. Italy Viral Vector Manufacturing Market Size (2018-2029) & (US$ Million)
    Figure 43. Russia Viral Vector Manufacturing Market Size (2018-2029) & (US$ Million)
    Figure 44. Nordic Countries Viral Vector Manufacturing Market Size (2018-2029) & (US$ Million)
    Figure 45. Asia-Pacific Viral Vector Manufacturing Market Share by Region (2018-2029)
    Figure 46. China Viral Vector Manufacturing Market Size (2018-2029) & (US$ Million)
    Figure 47. Japan Viral Vector Manufacturing Market Size (2018-2029) & (US$ Million)
    Figure 48. South Korea Viral Vector Manufacturing Market Size (2018-2029) & (US$ Million)
    Figure 49. Southeast Asia Viral Vector Manufacturing Market Size (2018-2029) & (US$ Million)
    Figure 50. India Viral Vector Manufacturing Market Size (2018-2029) & (US$ Million)
    Figure 51. Australia Viral Vector Manufacturing Market Size (2018-2029) & (US$ Million)
    Figure 52. Latin America Viral Vector Manufacturing Market Share by Country (2018-2029)
    Figure 53. Mexico Viral Vector Manufacturing Market Size (2018-2029) & (US$ Million)
    Figure 54. Brazil Viral Vector Manufacturing Market Size (2018-2029) & (US$ Million)
    Figure 55. Middle East & Africa Viral Vector Manufacturing Market Share by Country (2018-2029)
    Figure 56. Turkey Viral Vector Manufacturing Market Size (2018-2029) & (US$ Million)
    Figure 57. Saudi Arabia Viral Vector Manufacturing Market Size (2018-2029) & (US$ Million)
    Figure 58. UAE Viral Vector Manufacturing Market Size (2018-2029) & (US$ Million)
    Figure 59. Bottom-up and Top-down Approaches for This Report
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3350

This license allows only one user to access the PDF.
Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS